BDRX
Biodexa Pharmaceuticals PlcCompany with tickers: BDRX
CIK
1643918
CUSIP
59564R880
Shares Outstanding
746,114
13F Activity (30d)
4 filings
4 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2024-06-13 | — | |
| 6-K | 2024-05-28 | 2024-05-24 | |
| 6-K | 2024-05-22 | — | |
| 6-K | 2024-05-21 | — | |
| 6-K | 2024-05-15 | — | |
| 6-K | 2024-04-30 | — | |
| 6-K | 2024-04-26 | — | |
| 20-F | 2024-04-19 | 2023-12-31 | |
| 6-K | 2024-04-19 | — | |
| 6-K | 2024-02-23 | — | |
| 6-K | 2024-01-22 | — | |
| 6-K | 2023-12-29 | — | |
| 6-K | 2023-12-21 | — | |
| 6-K | 2023-12-06 | — | |
| 6-K | 2023-11-27 | — | |
| 6-K | 2023-10-03 | — | |
| 6-K | 2023-09-29 | 2023-06-30 | |
| 6-K | 2023-07-24 | — | |
| 6-K | 2023-07-10 | — | |
| 6-K | 2023-07-06 | — | |
| 6-K | 2023-06-22 | — | |
| 6-K | 2023-06-20 | — | |
| 6-K | 2023-06-15 | — | |
| 6-K | 2023-06-14 | — | |
| 6-K | 2023-06-01 | — | |
| 6-K | 2023-05-26 | — | |
| 6-K | 2023-05-24 | 2023-05-23 | |
| 6-K | 2023-05-22 | — | |
| 6-K | 2023-05-18 | — | |
| 20-F | 2023-04-28 | 2022-12-31 | |
| 6-K | 2023-04-28 | — | |
| 6-K | 2023-04-19 | — | |
| 6-K | 2023-04-12 | 2023-04-11 | |
| 6-K | 2023-04-07 | — | |
| 6-K | 2023-04-05 | — | |
| 6-K | 2023-04-04 | — | |
| 6-K | 2023-03-30 | — | |
| 6-K | 2023-03-29 | — | |
| 6-K | 2023-03-27 | — | |
| 6-K | 2023-03-24 | — | |
| 6-K | 2023-03-10 | — | |
| 6-K | 2023-03-08 | — | |
| 6-K | 2023-02-15 | — | |
| 6-K | 2023-02-09 | 2023-02-07 | |
| 6-K | 2023-02-02 | — | |
| 6-K | 2023-01-26 | — | |
| 6-K | 2023-01-23 | — | |
| 6-K | 2023-01-12 | — | |
| 6-K | 2023-01-11 | — | |
| 6-K | 2023-01-06 | — |
Showing 51–100 of 146 filings